Global Opioid-Induced Constipation (OIC) Treatment Market Growth (Status and Outlook) 2024-2030

December 2024 | 87 pages | ID: GF1800C890D3EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Opioid-Induced Constipation (OIC) Treatment market size was valued at US$ 2476 million in 2023. With growing demand in downstream market, the Opioid-Induced Constipation (OIC) Treatment is forecast to a readjusted size of US$ 3407.6 million by 2030 with a CAGR of 4.7% during review period.

The research report highlights the growth potential of the global Opioid-Induced Constipation (OIC) Treatment market. Opioid-Induced Constipation (OIC) Treatment are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Opioid-Induced Constipation (OIC) Treatment. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Opioid-Induced Constipation (OIC) Treatment market.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Key Features:

The report on Opioid-Induced Constipation (OIC) Treatment market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Opioid-Induced Constipation (OIC) Treatment market. It may include historical data, market segmentation by Type (e.g., Oral, Parenteral (Subcutaneous Injection)), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Opioid-Induced Constipation (OIC) Treatment market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Opioid-Induced Constipation (OIC) Treatment market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Opioid-Induced Constipation (OIC) Treatment industry. This include advancements in Opioid-Induced Constipation (OIC) Treatment technology, Opioid-Induced Constipation (OIC) Treatment new entrants, Opioid-Induced Constipation (OIC) Treatment new investment, and other innovations that are shaping the future of Opioid-Induced Constipation (OIC) Treatment.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Opioid-Induced Constipation (OIC) Treatment market. It includes factors influencing customer ' purchasing decisions, preferences for Opioid-Induced Constipation (OIC) Treatment product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Opioid-Induced Constipation (OIC) Treatment market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Opioid-Induced Constipation (OIC) Treatment market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Opioid-Induced Constipation (OIC) Treatment market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Opioid-Induced Constipation (OIC) Treatment industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Opioid-Induced Constipation (OIC) Treatment market.

Market Segmentation:

Opioid-Induced Constipation (OIC) Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type

• Oral
• Parenteral (Subcutaneous Injection)

Segmentation by application

• Drug Store
• Independent Pharmacies
• Hospital Pharmacies

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• GlaxoSmithKline
• AstraZeneca
• Pfizer
• S.L.A. Pharma
• AIKO Biotechnology
• Cubist Pharmaceuticals
• Salix Pharmaceuticals
• Takeda Pharmaceutical

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size 2019-2030
  2.1.2 Opioid-Induced Constipation (OIC) Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Opioid-Induced Constipation (OIC) Treatment Segment by Type
  2.2.1 Oral
  2.2.2 Parenteral (Subcutaneous Injection)
2.3 Opioid-Induced Constipation (OIC) Treatment Market Size by Type
  2.3.1 Opioid-Induced Constipation (OIC) Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Type (2019-2024)
2.4 Opioid-Induced Constipation (OIC) Treatment Segment by Application
  2.4.1 Drug Store
  2.4.2 Independent Pharmacies
  2.4.3 Hospital Pharmacies
2.5 Opioid-Induced Constipation (OIC) Treatment Market Size by Application
  2.5.1 Opioid-Induced Constipation (OIC) Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Application (2019-2024)

3 OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET SIZE BY PLAYER

3.1 Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Players
  3.1.1 Global Opioid-Induced Constipation (OIC) Treatment Revenue by Players (2019-2024)
  3.1.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Opioid-Induced Constipation (OIC) Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT BY REGIONS

4.1 Opioid-Induced Constipation (OIC) Treatment Market Size by Regions (2019-2024)
4.2 Americas Opioid-Induced Constipation (OIC) Treatment Market Size Growth (2019-2024)
4.3 APAC Opioid-Induced Constipation (OIC) Treatment Market Size Growth (2019-2024)
4.4 Europe Opioid-Induced Constipation (OIC) Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2019-2024)
5.2 Americas Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2019-2024)
5.3 Americas Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2019-2024)
6.2 APAC Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2019-2024)
6.3 APAC Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Opioid-Induced Constipation (OIC) Treatment by Country (2019-2024)
7.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2019-2024)
7.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment by Region (2019-2024)
8.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL OPIOID-INDUCED CONSTIPATION (OIC) TREATMENT MARKET FORECAST

10.1 Global Opioid-Induced Constipation (OIC) Treatment Forecast by Regions (2025-2030)
  10.1.1 Global Opioid-Induced Constipation (OIC) Treatment Forecast by Regions (2025-2030)
  10.1.2 Americas Opioid-Induced Constipation (OIC) Treatment Forecast
  10.1.3 APAC Opioid-Induced Constipation (OIC) Treatment Forecast
  10.1.4 Europe Opioid-Induced Constipation (OIC) Treatment Forecast
  10.1.5 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Forecast
10.2 Americas Opioid-Induced Constipation (OIC) Treatment Forecast by Country (2025-2030)
  10.2.1 United States Opioid-Induced Constipation (OIC) Treatment Market Forecast
  10.2.2 Canada Opioid-Induced Constipation (OIC) Treatment Market Forecast
  10.2.3 Mexico Opioid-Induced Constipation (OIC) Treatment Market Forecast
  10.2.4 Brazil Opioid-Induced Constipation (OIC) Treatment Market Forecast
10.3 APAC Opioid-Induced Constipation (OIC) Treatment Forecast by Region (2025-2030)
  10.3.1 China Opioid-Induced Constipation (OIC) Treatment Market Forecast
  10.3.2 Japan Opioid-Induced Constipation (OIC) Treatment Market Forecast
  10.3.3 Korea Opioid-Induced Constipation (OIC) Treatment Market Forecast
  10.3.4 Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Forecast
  10.3.5 India Opioid-Induced Constipation (OIC) Treatment Market Forecast
  10.3.6 Australia Opioid-Induced Constipation (OIC) Treatment Market Forecast
10.4 Europe Opioid-Induced Constipation (OIC) Treatment Forecast by Country (2025-2030)
  10.4.1 Germany Opioid-Induced Constipation (OIC) Treatment Market Forecast
  10.4.2 France Opioid-Induced Constipation (OIC) Treatment Market Forecast
  10.4.3 UK Opioid-Induced Constipation (OIC) Treatment Market Forecast
  10.4.4 Italy Opioid-Induced Constipation (OIC) Treatment Market Forecast
  10.4.5 Russia Opioid-Induced Constipation (OIC) Treatment Market Forecast
10.5 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Forecast by Region (2025-2030)
  10.5.1 Egypt Opioid-Induced Constipation (OIC) Treatment Market Forecast
  10.5.2 South Africa Opioid-Induced Constipation (OIC) Treatment Market Forecast
  10.5.3 Israel Opioid-Induced Constipation (OIC) Treatment Market Forecast
  10.5.4 Turkey Opioid-Induced Constipation (OIC) Treatment Market Forecast
  10.5.5 GCC Countries Opioid-Induced Constipation (OIC) Treatment Market Forecast
10.6 Global Opioid-Induced Constipation (OIC) Treatment Forecast by Type (2025-2030)
10.7 Global Opioid-Induced Constipation (OIC) Treatment Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 GlaxoSmithKline
  11.1.1 GlaxoSmithKline Company Information
  11.1.2 GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Product Offered
  11.1.3 GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 GlaxoSmithKline Main Business Overview
  11.1.5 GlaxoSmithKline Latest Developments
11.2 AstraZeneca
  11.2.1 AstraZeneca Company Information
  11.2.2 AstraZeneca Opioid-Induced Constipation (OIC) Treatment Product Offered
  11.2.3 AstraZeneca Opioid-Induced Constipation (OIC) Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 AstraZeneca Main Business Overview
  11.2.5 AstraZeneca Latest Developments
11.3 Pfizer
  11.3.1 Pfizer Company Information
  11.3.2 Pfizer Opioid-Induced Constipation (OIC) Treatment Product Offered
  11.3.3 Pfizer Opioid-Induced Constipation (OIC) Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Pfizer Main Business Overview
  11.3.5 Pfizer Latest Developments
11.4 S.L.A. Pharma
  11.4.1 S.L.A. Pharma Company Information
  11.4.2 S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Product Offered
  11.4.3 S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 S.L.A. Pharma Main Business Overview
  11.4.5 S.L.A. Pharma Latest Developments
11.5 AIKO Biotechnology
  11.5.1 AIKO Biotechnology Company Information
  11.5.2 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Product Offered
  11.5.3 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 AIKO Biotechnology Main Business Overview
  11.5.5 AIKO Biotechnology Latest Developments
11.6 Cubist Pharmaceuticals
  11.6.1 Cubist Pharmaceuticals Company Information
  11.6.2 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product Offered
  11.6.3 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Cubist Pharmaceuticals Main Business Overview
  11.6.5 Cubist Pharmaceuticals Latest Developments
11.7 Salix Pharmaceuticals
  11.7.1 Salix Pharmaceuticals Company Information
  11.7.2 Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product Offered
  11.7.3 Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Salix Pharmaceuticals Main Business Overview
  11.7.5 Salix Pharmaceuticals Latest Developments
11.8 Takeda Pharmaceutical
  11.8.1 Takeda Pharmaceutical Company Information
  11.8.2 Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Product Offered
  11.8.3 Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Takeda Pharmaceutical Main Business Overview
  11.8.5 Takeda Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Opioid-Induced Constipation (OIC) Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Parenteral (Subcutaneous Injection)
Table 4. Opioid-Induced Constipation (OIC) Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Type (2019-2024)
Table 7. Opioid-Induced Constipation (OIC) Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Application (2019-2024)
Table 10. Global Opioid-Induced Constipation (OIC) Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Player (2019-2024)
Table 12. Opioid-Induced Constipation (OIC) Treatment Key Players Head office and Products Offered
Table 13. Opioid-Induced Constipation (OIC) Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Regions (2019-2024)
Table 18. Global Opioid-Induced Constipation (OIC) Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Country (2019-2024)
Table 22. Americas Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Type (2019-2024)
Table 24. Americas Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Application (2019-2024)
Table 26. APAC Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Region (2019-2024)
Table 28. APAC Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Type (2019-2024)
Table 30. APAC Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Application (2019-2024)
Table 32. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Country (2019-2024)
Table 34. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Type (2019-2024)
Table 36. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Opioid-Induced Constipation (OIC) Treatment
Table 45. Key Market Challenges & Risks of Opioid-Induced Constipation (OIC) Treatment
Table 46. Key Industry Trends of Opioid-Induced Constipation (OIC) Treatment
Table 47. Global Opioid-Induced Constipation (OIC) Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Opioid-Induced Constipation (OIC) Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Opioid-Induced Constipation (OIC) Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Opioid-Induced Constipation (OIC) Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. GlaxoSmithKline Details, Company Type, Opioid-Induced Constipation (OIC) Treatment Area Served and Its Competitors
Table 52. GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Product Offered
Table 53. GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. GlaxoSmithKline Main Business
Table 55. GlaxoSmithKline Latest Developments
Table 56. AstraZeneca Details, Company Type, Opioid-Induced Constipation (OIC) Treatment Area Served and Its Competitors
Table 57. AstraZeneca Opioid-Induced Constipation (OIC) Treatment Product Offered
Table 58. AstraZeneca Main Business
Table 59. AstraZeneca Opioid-Induced Constipation (OIC) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. AstraZeneca Latest Developments
Table 61. Pfizer Details, Company Type, Opioid-Induced Constipation (OIC) Treatment Area Served and Its Competitors
Table 62. Pfizer Opioid-Induced Constipation (OIC) Treatment Product Offered
Table 63. Pfizer Main Business
Table 64. Pfizer Opioid-Induced Constipation (OIC) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Pfizer Latest Developments
Table 66. S.L.A. Pharma Details, Company Type, Opioid-Induced Constipation (OIC) Treatment Area Served and Its Competitors
Table 67. S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Product Offered
Table 68. S.L.A. Pharma Main Business
Table 69. S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. S.L.A. Pharma Latest Developments
Table 71. AIKO Biotechnology Details, Company Type, Opioid-Induced Constipation (OIC) Treatment Area Served and Its Competitors
Table 72. AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Product Offered
Table 73. AIKO Biotechnology Main Business
Table 74. AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. AIKO Biotechnology Latest Developments
Table 76. Cubist Pharmaceuticals Details, Company Type, Opioid-Induced Constipation (OIC) Treatment Area Served and Its Competitors
Table 77. Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product Offered
Table 78. Cubist Pharmaceuticals Main Business
Table 79. Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Cubist Pharmaceuticals Latest Developments
Table 81. Salix Pharmaceuticals Details, Company Type, Opioid-Induced Constipation (OIC) Treatment Area Served and Its Competitors
Table 82. Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product Offered
Table 83. Salix Pharmaceuticals Main Business
Table 84. Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Salix Pharmaceuticals Latest Developments
Table 86. Takeda Pharmaceutical Details, Company Type, Opioid-Induced Constipation (OIC) Treatment Area Served and Its Competitors
Table 87. Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Product Offered
Table 88. Takeda Pharmaceutical Main Business
Table 89. Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Takeda Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Opioid-Induced Constipation (OIC) Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Opioid-Induced Constipation (OIC) Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Opioid-Induced Constipation (OIC) Treatment Sales Market Share by Country/Region (2023)
Figure 8. Opioid-Induced Constipation (OIC) Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Type in 2023
Figure 10. Opioid-Induced Constipation (OIC) Treatment in Drug Store
Figure 11. Global Opioid-Induced Constipation (OIC) Treatment Market: Drug Store (2019-2024) & ($ Millions)
Figure 12. Opioid-Induced Constipation (OIC) Treatment in Independent Pharmacies
Figure 13. Global Opioid-Induced Constipation (OIC) Treatment Market: Independent Pharmacies (2019-2024) & ($ Millions)
Figure 14. Opioid-Induced Constipation (OIC) Treatment in Hospital Pharmacies
Figure 15. Global Opioid-Induced Constipation (OIC) Treatment Market: Hospital Pharmacies (2019-2024) & ($ Millions)
Figure 16. Global Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Application in 2023
Figure 17. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Player in 2023
Figure 18. Global Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Opioid-Induced Constipation (OIC) Treatment Market Size 2019-2024 ($ Millions)
Figure 20. APAC Opioid-Induced Constipation (OIC) Treatment Market Size 2019-2024 ($ Millions)
Figure 21. Europe Opioid-Induced Constipation (OIC) Treatment Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size 2019-2024 ($ Millions)
Figure 23. Americas Opioid-Induced Constipation (OIC) Treatment Value Market Share by Country in 2023
Figure 24. United States Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Region in 2023
Figure 29. APAC Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Type in 2023
Figure 30. APAC Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Application in 2023
Figure 31. China Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Country in 2023
Figure 38. Europe Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Type (2019-2024)
Figure 39. Europe Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Application (2019-2024)
Figure 40. Germany Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Opioid-Induced Constipation (OIC) Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 54. APAC Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 55. Europe Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 57. United States Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 58. Canada Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 61. China Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 62. Japan Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 63. Korea Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 65. India Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 66. Australia Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 67. Germany Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 68. France Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 69. UK Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 70. Italy Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 71. Russia Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 72. Spain Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 75. Israel Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Opioid-Induced Constipation (OIC) Treatment Market Size 2025-2030 ($ Millions)
Figure 78. Global Opioid-Induced Constipation (OIC) Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Opioid-Induced Constipation (OIC) Treatment Market Size Market Share Forecast by Application (2025-2030)